COVID-19 infection and vaccines: potential triggers of Herpesviridae reactivation
An. bras. dermatol
; 98(3): 347-354, May-June 2023. tab, graf
Article
in English
|
LILACS-Express
| LILACS
| ID: biblio-1439201
Responsible library:
BR1.1
ABSTRACT
Abstract Since the onset of the COVID-19 outbreak, numerous articles have highlighted a possible link between COVID-19 vaccination or infection and Herpesviridae co-infection or reactivation. The authors conducted an exhaustive literature review on this topic, the results of which are presented individually for each member of the Herpesviridae family Herpes Simplex Virus (HSV) types-1 (HSV-1) and 2 (HSV-2); Varicella-Zoster Virus (VZV); Epstein-Barr Virus (EBV); Cytomegalovirus (CMV); HHV-6; HHV-7; and HHV-8. These human herpesviruses can serve as prognostic markers for the COVID-19 infection and may even underlie some of the clinical manifestations initially attributed to SARS-CoV-2. In addition to SARS-CoV-2 infection, all corresponding vaccines approved to date in Europe appear capable of inducing herpesvirus reactivation. It is important to consider all viruses of the Herpesviridae family when managing patients infected with or recently vaccinated against COVID-19.
Full text:
Available
Collection:
International databases
Health context:
Sustainable Health Agenda for the Americas
Health problem:
Goal 10: Communicable diseases
Database:
LILACS
Language:
English
Journal:
An. bras. dermatol
Journal subject:
Dermatology
Year:
2023
Document type:
Article
Affiliation country:
Spain
Institution/Affiliation country:
Miguel Servet University Hospital/ES